Trial Profile
68Ga-PSMA PET/CT for detection of recurrent prostate cancer: Comparison with 18F-fluoride PET/CT, MRI and DW-MRI
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 23 Aug 2016
Price :
$35
*
At a glance
- Drugs Gallium (68Ga) gozetotide (Primary) ; Fluoride
- Indications Prostate cancer
- Focus Diagnostic use
- 20 Aug 2016 Status changed from recruiting to completed.
- 25 Feb 2015 New trial record